Carlos Fernandez Del Castillo, MD | Authors

November 01, 2000

This year, approximately 40% of the 28,300 patients diagnosed with pancreatic carcinoma in the United States will present with locally advanced disease. Radiotherapeutic approaches are often employed, as these patients